356 related articles for article (PubMed ID: 6121049)
1. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
Nakaki T; Nakadate T; Yamamoto S; Kato R
J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
Carter RF; Bitar KN; Zfass AM; Makhlouf GM
Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
[TBL] [Abstract][Full Text] [Related]
3. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
4. Further studies on prostaglandin E1-induced jejunal secretion of water and electrolytes in man, with special reference to the influence of ethacrynic acid, furosemide, and aspirin.
Matuchansky C; Mary JY; Bernier JJ
Gastroenterology; 1976 Aug; 71(2):274-81. PubMed ID: 939389
[TBL] [Abstract][Full Text] [Related]
5. Role of alpha 2-adrenoceptors in the regulation of intestinal water transport.
Liu L; Coupar IM
Br J Pharmacol; 1997 Mar; 120(5):892-8. PubMed ID: 9138696
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.
Nakaki T; Nakadate T; Yamamoto S; Kato R
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):181-4. PubMed ID: 6121295
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dibutyryl cyclic AMP-induced insulin release by alpha-2 adrenergic stimulation.
Nakaki T; Nakadate T; Yamamoto S; Kato R
Life Sci; 1983 Jan; 32(3):191-5. PubMed ID: 6130458
[TBL] [Abstract][Full Text] [Related]
8. Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo.
Krejs GJ; Barkley RM; Read NW; Fordtran JS
J Clin Invest; 1978 May; 61(5):1337-45. PubMed ID: 659596
[TBL] [Abstract][Full Text] [Related]
9. VIP and PGE1 activate adenylate cyclase in rat intestinal epithelial cell membranes via different mechanisms.
Beubler E
Eur J Pharmacol; 1981 Aug; 74(1):67-72. PubMed ID: 7198581
[TBL] [Abstract][Full Text] [Related]
10. Alpha 2-adrenergic stimulation counteracts the metabolic effects of vasoactive intestinal peptide in isolated rat enterocytes.
Vidal H; Riou JP
Endocrinology; 1989 Jun; 124(6):3117-21. PubMed ID: 2470585
[TBL] [Abstract][Full Text] [Related]
11. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
Simon B; Kather H
Gastroenterology; 1978 Apr; 74(4):722-5. PubMed ID: 204535
[TBL] [Abstract][Full Text] [Related]
12. Homologous desensitization of rat heart cells to beta-adrenergic stimulation and the absence of alpha-adrenergic or prostaglandin E1 effects.
Fisher RA; Harary I; Thomas JA
J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):449-60. PubMed ID: 6151955
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by morphine of prostaglandin E1-stimulated secretion and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum in vivo.
Beubler E; Lembeck F
Br J Pharmacol; 1980 Mar; 68(3):513-8. PubMed ID: 6301596
[TBL] [Abstract][Full Text] [Related]
14. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
[TBL] [Abstract][Full Text] [Related]
15. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
Hirota A; Kiuchi Y; Nii H; Gregory DS
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclic AMP-mediated intestinal hypersecretion by pituitary extracts from rats pretreated with cholera toxin.
Lönnroth I; Lange S
Med Biol; 1984; 62(5):290-4. PubMed ID: 6099456
[TBL] [Abstract][Full Text] [Related]
17. Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system.
Mangeat P; Marvaldi J; Ahmed OA; Marchis-Mouren G
Regul Pept; 1981 Mar; 1(6):397-414. PubMed ID: 6262879
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
Nakaki T; Nakadate T; Yamamoto S; Kato R
Mol Pharmacol; 1983 Jan; 23(1):228-34. PubMed ID: 6135143
[No Abstract] [Full Text] [Related]
19. Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility.
Doherty NS; Hancock AA
J Pharmacol Exp Ther; 1983 May; 225(2):269-74. PubMed ID: 6132991
[TBL] [Abstract][Full Text] [Related]
20. Colonic secretion mediated by prostaglandin E2 and 5-hydroxytryptamine may contribute to diarrhea due to morphine withdrawal in the rat.
Beubler E; Bukhave K; Rask-Madsen J
Gastroenterology; 1984 Nov; 87(5):1042-8. PubMed ID: 6090256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
